Cytokinetics Inc (CYTK)
65.38
+0.58
(+0.90%)
USD |
NASDAQ |
Apr 26, 16:00
65.38
0.00 (0.00%)
After-Hours: 16:40
Cytokinetics Cash from Investing (TTM): 239.25M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 239.25M |
September 30, 2023 | 349.91M |
June 30, 2023 | -15.50M |
March 31, 2023 | -32.36M |
December 31, 2022 | -262.13M |
September 30, 2022 | -244.05M |
June 30, 2022 | -160.39M |
March 31, 2022 | -206.78M |
December 31, 2021 | -147.78M |
September 30, 2021 | -368.73M |
June 30, 2021 | -261.04M |
March 31, 2021 | -245.28M |
December 31, 2020 | -196.52M |
September 30, 2020 | -128.16M |
June 30, 2020 | -13.46M |
March 31, 2020 | -50.86M |
December 31, 2019 | -74.71M |
September 30, 2019 | 57.07M |
June 30, 2019 | 46.06M |
March 31, 2019 | 4.641M |
December 31, 2018 | 5.133M |
September 30, 2018 | 9.388M |
June 30, 2018 | 46.37M |
March 31, 2018 | 66.61M |
December 31, 2017 | -65.83M |
Date | Value |
---|---|
September 30, 2017 | -138.56M |
June 30, 2017 | -164.25M |
March 31, 2017 | -144.22M |
December 31, 2016 | -52.08M |
September 30, 2016 | 15.30M |
June 30, 2016 | 12.64M |
March 31, 2016 | 28.00M |
December 31, 2015 | 16.06M |
September 30, 2015 | -3.044M |
June 30, 2015 | -4.283M |
March 31, 2015 | -7.282M |
December 31, 2014 | -4.049M |
September 30, 2014 | -4.54M |
June 30, 2014 | -22.20M |
March 31, 2014 | -40.85M |
December 31, 2013 | -1.519M |
September 30, 2013 | -0.716M |
June 30, 2013 | -32.10M |
March 31, 2013 | -23.40M |
December 31, 2012 | -28.82M |
September 30, 2012 | -26.64M |
June 30, 2012 | 16.60M |
March 31, 2012 | 19.28M |
December 31, 2011 | 25.30M |
September 30, 2011 | 7.86M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-368.73M
Minimum
Sep 2021
349.91M
Maximum
Sep 2023
-90.29M
Average
-128.16M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Johnson & Johnson | 878.00M |
Eli Lilly and Co | -7.153B |
Viking Therapeutics Inc | -641.08M |
Madrigal Pharmaceuticals Inc | -502.52M |